| scholarly article | Q13442814 |
| P2093 | author name string | J Ni | |
| P A Moore | |||
| B B Aggarwal | |||
| B G Darnay | |||
| P2860 | cites work | TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor | Q36380989 |
| Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. | Q36566021 | ||
| The p60 tumor necrosis factor (TNF) receptor-associated kinase (TRAK) binds residues 344-397 within the cytoplasmic domain involved in TNF signaling | Q41333986 | ||
| NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation | Q45754430 | ||
| IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling | Q24309107 | ||
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
| IKAP is a scaffold protein of the IkappaB kinase complex | Q24316436 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176 | Q24319941 | ||
| ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5 | Q24321707 | ||
| Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1 | Q24323286 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB | Q24533857 | ||
| Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 | Q24642851 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase | Q28131695 | ||
| Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily | Q28239398 | ||
| Identification and characterization of an IkappaB kinase | Q28245341 | ||
| CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase | Q28270530 | ||
| Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase | Q28278061 | ||
| Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting [...] | Q28280257 | ||
| TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
| The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor | Q28285539 | ||
| TRAF6 is a signal transducer for interleukin-1 | Q28291934 | ||
| MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 | Q28302936 | ||
| Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region | Q28511583 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death | Q28609905 | ||
| MyD88: an adapter that recruits IRAK to the IL-1 receptor complex | Q28611795 | ||
| Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 | ||
| Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases | Q33777633 | ||
| Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression | Q33786551 | ||
| Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 | Q36004058 | ||
| JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? | Q36070075 | ||
| Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta | Q36285724 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 7724-31 | |
| P577 | publication date | 1999-03-19 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif | |
| P478 | volume | 274 |
| Q35643623 | 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells |
| Q90124747 | A TRAF6 genetic variant is associated with low bone mineral density in rheumatoid arthritis |
| Q27919649 | A functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF. |
| Q41831683 | A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK) |
| Q24292059 | A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6 |
| Q53364532 | A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals. |
| Q44329387 | Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types |
| Q93046970 | Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice |
| Q89848783 | Amaranthus mangostanus Inhibits the Differentiation of Osteoclasts and Prevents Ovariectomy-Induced Bone Loss |
| Q30993599 | Analysis of expressed sequence tags from Maize mosaic rhabdovirus-infected gut tissues of Peregrinus maidis reveals the presence of key components of insect innate immunity |
| Q40871220 | Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis |
| Q50770025 | Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB. |
| Q35925874 | Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily |
| Q37496714 | Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L. |
| Q36369124 | Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies |
| Q35853244 | Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity |
| Q93053543 | BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells |
| Q35415849 | Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF- |
| Q34366449 | Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond |
| Q35145622 | Biology of the TRANCE axis |
| Q92704323 | Bone Regeneration, Reconstruction and Use of Osteogenic Cells; from Basic Knowledge, Animal Models to Clinical Trials |
| Q35995710 | C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway |
| Q39855419 | CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling |
| Q44301311 | Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents |
| Q52956230 | Castalagin Exerts Inhibitory Effects on Osteoclastogenesis Through Blocking a Broad Range of Signaling Pathways with Low Cytotoxicity. |
| Q35173015 | Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent manner |
| Q90278559 | Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration |
| Q41990475 | Characterization and Mechanistic Studies of a Novel Melanoma-Targeting Construct Containing IκBa for Specific Inhibition of Nuclear Factor-κB Activity |
| Q28186559 | Characterization of a cascade of protein interactions initiated at the IL-1 receptor |
| Q37464897 | Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease |
| Q52942810 | Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways. |
| Q34225114 | Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands |
| Q39929790 | Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis |
| Q34094406 | Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway |
| Q43830972 | Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines |
| Q40582077 | Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells |
| Q48058406 | Development of 1-Amino-4-(phenylamino)anthraquinone-2-sulfonate Sodium Derivatives as a New Class of Inhibitors of RANKL-Induced Osteoclastogenesis |
| Q33738074 | Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling. |
| Q24302174 | Distinct molecular mechanism for initiating TRAF6 signalling |
| Q28546890 | Disulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agent |
| Q36739991 | Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis |
| Q36953281 | Effects of a GSK-3β inhibitor on the renal expression levels of RANK, RANKL and NF-κB in a rat model of diabetic nephropathy |
| Q28207648 | Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40 |
| Q47146522 | Effects of triethylene glycol dimethacrylate (TEGDMA) on the odontoclastic differentiation ability of human dental pulp cells. |
| Q53019890 | Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice. |
| Q41981419 | Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression |
| Q37396119 | Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. |
| Q40235625 | Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma |
| Q57533748 | Expression of functional RANK on mature rat and human osteoclasts |
| Q38462802 | Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells |
| Q43000284 | Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stim |
| Q35079256 | Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members |
| Q24678660 | Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway |
| Q29617421 | Genetic regulation of osteoclast development and function |
| Q35105452 | Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 |
| Q90463796 | Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma |
| Q35839884 | Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. |
| Q47595585 | Gα12 regulates osteoclastogenesis by modulating NFATc1 expression |
| Q40883179 | Human chorionic gonadotropin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 induced by tumor necrosis factor |
| Q64262538 | I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma |
| Q36806362 | IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. |
| Q36251949 | Identification and application of anti-inflammatory compounds screening system based on RAW264.7 cells stably expressing NF-κB-dependent SEAP reporter gene |
| Q35763320 | Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoprotein |
| Q53584487 | Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women. |
| Q36924500 | Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration |
| Q39085876 | Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice |
| Q93041137 | Inhibitory Effect of Probenecid on Osteoclast Formation via JNK, ROS and COX-2 |
| Q39251233 | Inhibitory effects of tert-butylhydroquinone on osteoclast differentiation via up-regulation of heme oxygenase-1 and down-regulation of HMGB1 release and NFATc1 expression |
| Q39919544 | Interleukin-1 receptor type 1 is a substrate for gamma-secretase-dependent regulated intramembrane proteolysis. |
| Q44754181 | Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. |
| Q64065423 | KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1 |
| Q36770410 | Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways |
| Q40752073 | Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha |
| Q35913362 | Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo |
| Q44508743 | Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation |
| Q52578848 | Mechanisms involved in normal and pathological osteoclastogenesis. |
| Q37146973 | Mechanisms of tooth eruption and orthodontic tooth movement |
| Q38442845 | Microarray gene expression during early healing of GBR-treated calvarial critical size defects. |
| Q34285044 | Modification of Cysteine 179 of IκBα Kinase by Nimbolide Leads to Down-regulation of NF-κB-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents |
| Q90275102 | Modular Architecture of the STING C-Terminal Tail Allows Interferon and NF-κB Signaling Adaptation |
| Q42642070 | Molecular biology of bone remodelling |
| Q40698580 | NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases |
| Q41907549 | NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2. |
| Q35208356 | NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses |
| Q90397955 | New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity |
| Q24619151 | New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer |
| Q37748586 | New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. |
| Q39703528 | Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB. |
| Q35175282 | Nuclear transcription factor-kappaB in Hodgkin's disease |
| Q38000081 | Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis |
| Q40617978 | Oleandrin suppresses activation of nuclear transcription factor-κB and activator protein-1 and potentiates apoptosis induced by ceramide |
| Q73211247 | Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand |
| Q35755039 | Osteoclasts: New Insights |
| Q40673196 | Pathologic Findings in NEMO Deficiency: A Surgical and Autopsy Survey |
| Q33961554 | Pathway-based association analyses identified TRAIL pathway for osteoporotic fractures |
| Q28208696 | Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family |
| Q73731212 | Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis |
| Q38866853 | Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways |
| Q24598872 | RANK is essential for osteoclast and lymph node development |
| Q37108966 | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism |
| Q26747442 | RANK-RANKL signalling in cancer |
| Q41107411 | RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. |
| Q39590554 | RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation |
| Q38306944 | RANKL/OPG; Critical role in bone physiology. |
| Q58776864 | Rab GTPases in Osteoclastic Endomembrane Systems |
| Q38695357 | Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation |
| Q34333628 | Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis |
| Q40633180 | Receptor Activator of NF-κB Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis |
| Q24537518 | Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 |
| Q34086847 | Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases |
| Q37217673 | Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone |
| Q38113962 | Regulation of PI-3-Kinase and Akt Signaling in T Lymphocytes and Other Cells by TNFR Family Molecules |
| Q36702425 | Regulation of neurite growth by tumour necrosis superfamily member RANKL. |
| Q34269354 | Regulation of proliferation, survival and apoptosis by members of the TNF superfamily |
| Q34728971 | Regulatory mechanisms of osteoblast and osteoclast differentiation |
| Q24311417 | Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis |
| Q24295323 | SASH1 is a scaffold molecule in endothelial TLR4 signaling |
| Q60933379 | SPA0355 prevents ovariectomy-induced bone loss in mice |
| Q34090842 | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. |
| Q33957047 | Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products |
| Q36043987 | Signal peptide mutations in RANK prevent downstream activation of NF-κB. |
| Q24534564 | Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB |
| Q33782305 | Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors |
| Q29616428 | Signalling pathways of the TNF superfamily: a double-edged sword |
| Q24321363 | Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation |
| Q28066288 | Smad-dependent mechanisms of inflammatory bone destruction |
| Q36949929 | Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts |
| Q54352725 | Structure of the TRAF4 TRAF domain with a coiled-coil domain and its implications for the TRAF4 signalling pathway. |
| Q38743328 | Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6. |
| Q24324222 | TAK1-dependent signaling requires functional interaction with TAB2/TAB3 |
| Q39698378 | TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination |
| Q33416004 | TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses |
| Q40119268 | TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation |
| Q28142620 | TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src |
| Q22253885 | TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation |
| Q40641517 | TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor |
| Q39092456 | Taurine exerts anti-osteoclastogenesis activity via inhibiting ROS generation, JNK phosphorylation and COX-2 expression in RAW264.7 cells |
| Q36520887 | The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells. |
| Q24654977 | The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL |
| Q33976649 | The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6. |
| Q28198125 | The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators |
| Q37973113 | The adaptor protein p62/SQSTM1 in osteoclast signaling pathways |
| Q38719373 | The dental resin monomers HEMA and TEGDMA have inhibitory effects on osteoclast differentiation with low cytotoxicity |
| Q24683018 | The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games |
| Q37520235 | The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases. |
| Q24805207 | The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. |
| Q27619945 | The structural basis for the recognition of diverse receptor sequences by TRAF2 |
| Q38931685 | The structure function of the death domain of human IRAK-M. |
| Q24308947 | The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner |
| Q37185295 | Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling |
| Q33886695 | Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction |
| Q34135071 | Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. |
| Q35592741 | Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology |
| Q33307880 | Ubiquitin-mediated signalling and Paget's disease of bone |
| Q38303038 | VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kappa B to effect rotavirus-specific cellular responses |
| Q81344654 | Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-kappaB pathways |
| Q36202827 | Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. |
| Q44546925 | alpha-Melanocyte-stimulating hormone induces cell death in mast cells: involvement of NF-kappaB. |
| Q40624157 | alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages |
| Q40552100 | beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis |
Search more.